Mayo Clinic Proceedings


 

Clinical Development of Biosimilars in the United States: What Is the Median Time from Phase I Testing to the Approval and How Does It Affect the Access to Affordable Medications?

4 views
October 21, 2020
Comments 0
Login to view comments. Click here to Login